- Novel Mechanistic Insights into the Anti-cancer Mode of Arsenic Trioxide
Md Wahiduzzaman et al, 2020, Current Cancer Drug Targets CrossRef - Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma
Sze-Kwan Lam et al, 2019, Oncogenesis CrossRef - Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts
Sze-Kwan Lam et al, 2017, Respiratory Research CrossRef - Targeting polyamine as a novel therapy in xenograft models of malignant pleural mesothelioma
Sze-Kwan Lam et al, 2020, Lung Cancer CrossRef - Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma
Sze-Kwan Lam et al, 2016, Lung Cancer CrossRef - Cytotoxicity and genotoxicity effects of arsenic trioxide on SQ20B human laryngeal carcinoma cells
Fatma Trabelsi et al, 2017, Experimental and Toxicologic Pathology CrossRef - A self-assembled RNA-triple helix hydrogel drug delivery system targeting triple-negative breast cancer
Lairong Ding et al, 2020, Journal of Materials Chemistry B CrossRef - What can independent research for mesothelioma achieve to treat this orphan disease?
Alice Guazzelli et al, 2019, Expert Opinion on Investigational Drugs CrossRef - Arsenic: A Review of the Element’s Toxicity, Plant Interactions, and Potential Methods of Remediation
Bryan E. Hettick et al, 2015, Journal of Agricultural and Food Chemistry CrossRef - Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?
Arnaud Boyer et al, 2018, European Respiratory Review CrossRef - Arsenic trioxide reduces the expression of E2F1, cyclin E, and phosphorylation of PI3K signaling molecules in acute leukemia cells
Sanjay Kumar et al, 2021, Environmental Toxicology CrossRef